Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02911805 · ClinicalTrials.gov registry record · NA
Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation
A NA study of Vision Disorders, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT02911805: Active NA study of Vision Disorders, sponsored by VA Office of Research and Development.
NCT02911805 is a NA study of Vision Disorders that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 14 participants, below the 71-participant average among 5 other Vision Disorders trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02911805, a NA study of Vision Disorders, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine whether blood biomarker changes predict sight-saving benefits of exercise.
Primary Outcome
Early Treatment Diabetic Retinopathy Study (ETDRS) chart was used. Higher scores mean a better outcome. The number of correct responses (e.g., number of letters read correctly) from a subject assessed prior to start of the first session of the the 12 week study was subtracted from the number of correct responses elicited at the end of the last session of the study. The means of these differences for each study group (Balance Training vs Aerobic Exercise) were compared by two-tailed t-test.
Conditions Studied
Interventions
- BEHAVIORAL Aerobic exercise
- BEHAVIORAL Balance exercise
Study Locations (1)
Georgia
- Atlanta VA Medical and Rehab Center, Decatur, GA - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2015-06-10 |
| Est. Completion | 2028-01-28 |
| Phase | NA |
What the registry record for NCT02911805 still lists
NCT02911805 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 71-participant average among 5 other Vision Disorders trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Vision Disorders appearing as the primary indexed condition, and to 2 interventions - of which Aerobic exercise is the first listed.
NCT02911805 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT02911805 about?
NCT02911805 is a clinical study titled "Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation". This study will determine whether blood biomarker changes predict sight-saving benefits of exercise.
What is the current status of trial NCT02911805?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2015-06-10. Estimated completion is 2028-01-28.
What conditions does trial NCT02911805 study?
This clinical trial studies the following conditions: Vision Disorders.
What interventions are being tested in trial NCT02911805?
The interventions under investigation include: Aerobic exercise (BEHAVIORAL), Balance exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02911805?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02911805 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vision Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
RECRUITING · Phase 2
-
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
RECRUITING · Phase 3
-
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
ACTIVE NOT RECRUITING · Phase 1
-
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
ACTIVE NOT RECRUITING · Phase 2
-
Natural History Study of CEP290-Related Retinal Degeneration
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy